Envestnet Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Buy |
39,487
+26,500
| +204% | +$1.14M | ﹤0.01% | 2934 |
|
|
2025
Q1 | $449K | Buy |
12,987
+61
| +0.5% | +$2.11K | ﹤0.01% | 3695 |
|
|
2024
Q4 | $355K | Sell |
12,926
-2,949
| -19% | -$80.9K | ﹤0.01% | 3791 |
|
|
2024
Q3 | $404K | Sell |
15,875
-10,814
| -41% | -$275K | ﹤0.01% | 3651 |
|
|
2024
Q2 | $676K | Sell |
26,689
-6,112
| -19% | -$155K | ﹤0.01% | 3279 |
|
|
2024
Q1 | $1.01M | Sell |
32,801
-3,558
| -10% | -$110K | ﹤0.01% | 3023 |
|
|
2023
Q4 | $1.47M | Buy |
36,359
+7,105
| +24% | +$287K | ﹤0.01% | 2652 |
|
|
2023
Q3 | $771K | Buy |
29,254
+8,090
| +38% | +$213K | ﹤0.01% | 3000 |
|
|
2023
Q2 | $364K | Buy |
21,164
+437
| +2% | +$7.52K | ﹤0.01% | 3385 |
|
|
2023
Q1 | $344K | Buy |
20,727
+8,595
| +71% | +$143K | ﹤0.01% | 3371 |
|
|
2022
Q4 | $92.4K | Sell |
12,132
-249
| -2% | -$1.9K | ﹤0.01% | 3825 |
|
|
2022
Q3 | $123K | Buy |
+12,381
| New | +$123K | ﹤0.01% | 3699 |
|